Sanofi Said to Mull Counterbid for Actelion Amid J&J Talks

(Bloomberg) -- Sanofi is considering a counterbid for Actelion Ltd., potentially challenging a move by U.S. health-care giant Johnson & Johnson to acquire Europe’s largest biotechnology firm, peopl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.